DreamCIS

DreamCIS FCF Margin

The Free Cash Flow Margin of DreamCIS (223250.KQ) as of Oct 29, 2026 is 20.11 %. In the previous year, Free Cash Flow Margin was -2.69 % — a change of -847.89% (higher).

FCF Margin

20.11 %

YoY

-847.89%

Last updated:

Free Cash Flow Margin of DreamCIS is 2025 20.11 % . Free Cash Flow Margin of DreamCIS was 2024 -2.69 % . It decreases by -847.89% higher compared to the previous year.

The DreamCIS FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2018
24.96 KRW
Jan 1, 2019
19.11 KRW
Jan 1, 2020
13.39 KRW
Jan 1, 2021
18.21 KRW
Jan 1, 2022
21.75 KRW
Jan 1, 2023
11.80 KRW
Jan 1, 2024
-2.69 KRW
Jan 1, 2025
20.11 KRW
The DreamCIS FCF Margin history
YEARFCF MarginYoY
20.11 %-847.89%
-2.69 %-122.78%
11.80 %-45.74%
21.75 %+19.42%
18.21 %+36.04%
13.39 %-29.94%
19.11 %-23.43%
24.96 %+141.36%
10.34 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DreamCIS Stock analysis

What does DreamCIS do? DreamCIS Inc. is a company based in Seoul, South Korea, operating within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company went public on May 22, 2020, with its stock listed under the ticker 223250.KQ and ISIN KR7223250002. DreamCIS Inc. provides clinical online information and consultation services, focusing on regulatory post-marketing surveillance (rPMS), clinical trials, and non-interventional studies (NIS). The company serves both domestic and international markets, offering its services to clients seeking support in clinical research and regulatory compliance. Its headquarters are located in Seoul, South Korea. The company's website is http://www.dreamcis.com/, which serves as a primary source for further information about its services and operations. DreamCIS Inc. does not provide detailed information about its founding year, specific leadership, or financial figures beyond its IPO date, and no acquisitions or additional product names are mentioned in the provided data. The company's services are primarily aimed at facilitating clinical research and ensuring adherence to regulatory standards in the life sciences sector. DreamCIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DreamCIS stock

Free Cash Flow Margin of DreamCIS is 20.11 % in 2025.

Free Cash Flow Margin of DreamCIS changed from -2.69 % to 20.11 %, representing a -847.89% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin DreamCIS since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's DreamCIS with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — DreamCIS

All Key Metrics — DreamCIS